Migraine with Aura Characterized as Independent Risk Factor for Atrial Fibrillation
September 22, 2022

Adults with migraine with aura were found at significantly greater risk for AF and those younger than age 55 years were particularly vulnerable, write Mayo Clinic investigators.

Gepant sNDA for Chronic Migraine: Atogepant from AbbVie
June 28, 2022

If the atogepant label is expanded, the drug will be the only gepant approved for the broad indication of prevention of both episodic and chronic migraine.

"Migraine is a Tremendously Rewarding Disease to Treat"
April 22, 2022

Yale headache specialist Christopher Gottschalk, MD, talks about the opportunities to make a marked difference in the quality of patients' lives.

CGRP Inhibition for Migraine: Side Effects are Few but Pay Attention for These
April 11, 2022

The CGRP inhibitor class of injectable migraine preventive agents has a very favorable side effect profile but the drugs do come with some cautions, says Christopher Gottschalk, MD.

Rimegepant for Acute Migraine May Reduce Use of, Reliance on Opioids: New Data
April 07, 2022

Opioid refills were reduced by ~40% in the 9 months following an initial prescription for rimegepant among patients with migraine, a new study found.

Oral Gepants: Christopher Gottschalk, MD Tells the Origin Story, Highlights Broad Efficacy
April 01, 2022

The migraine-specific oral gepants are proving effective across the continuum of migraine frequency. Dr Gottschalk talks about their shaky start.

Gepants for Migraine Prevention: A Perfect Fit for Primary Care
March 30, 2022

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with headache specialist Peter McAllister, MD.

Migraine Medicine Transformed: Christopher Gottschalk, MD Discusses How We Got to CGRP Inhibition
March 28, 2022

Gottschalk says CGRP inhibitors have made "...a life-changing transformation in how we think about and the kind of expectations we set for migraine treatment."

Before Migraine Was a Disease: Headache Expert Christopher Gottschalk, MD, Remembers his Roots
March 25, 2022

Christopher Gottschalk, MD, a leader in migraine research and clinical care, talks about what drew him to headache medicine early on and what it used to be like.

Potential IBS-Migraine Association Seen in Nationwide Survey
March 18, 2022

Individuals with migraine were found more likely to have IBS and IBS was more prevalent in those with migraine; both associations were statistically significant.